User's Manual

Table Of Contents
Intended Audience
This literature is intended for use by professionals trained or experienced in device implant and/or follow-up
procedures.
INDICATIONS AND USAGE
These Boston Scientic Cardiac Resynchronization Therapy Debrillators (CRT-Ds) are indicated for patients
with heart failure who receive stable optimal pharmacologic therapy (OPT) for heart failure and who meet
any one of the following classications:
Moderate to severe heart failure (NYHA Class III-IV) with EF 35% and QRS duration 120 ms
Left bundle branch block (LBBB) with QRS duration 130 ms, EF 30%, and mild (NYHA Class II)
ischemic or nonischemic heart f ailure or asymptomatic (NYHA Class I) ischemic heart failure
CONTRAINDICATIONS
There are no contraindications for this device.
WARNINGS
General
Labeling knowledge. Read this manual thoroughly before implantation to avoid damage to the pulse
generator and/or lead. Such damage can result in patient injury or death.
For single patient use only. Do not reuse, reprocess, or resterilize. Reuse, reprocessing, or
resterilization may compromise the structural integrity of the device and/or lead to device failure which, in
turn, may result in patient injury, illness, or death. Reuse, reprocessing, or resterilization may also create
a risk of contamination of the device and/or cause patient infection or cross-infection, including, but not
limited to, the transmission of infectious disease(s) from one patient to another. Contamination of the
device may lead to injury, illness, or death of the patient.
4